WGS GeneDx Holdings Corp.

49.24USD-5.23%Mkt Cap: 1.48B USDP/E: —

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and inf…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap1.48B USD
Enterprise Value1.60B USD
Revenue (TTM)460.78M USD
Gross Profit298.17M USD
Net Income (TTM)-21.02M USD
Revenue/Share15.62 USD
Last Price49.24 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees1.3K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)37.84
PEG—
EV/EBITDA-43.72
EV/Revenue3.48
P/S3.20
P/B6.03
EPS (TTM)-3.76 USD
EPS (Forward)1.30 USD
52W Range
32.2112% of range170.87
52W High170.87 USD
52W Low32.21 USD
Profitability
Gross Margin69.74%
Oper. Margin-13.68%
EBITDA Margin-7.95%
Profit Margin-4.92%
ROE-6.82%
ROA-4.01%
ROIC-5.20%
ROCE-3.15%
Growth
Revenue Growth5.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF33.28M USD
CapEx (TTM)19.02M USD
FCF Margin-15.25%
FCF Yield-4.76%
Net Debt45.27M USD
Net Debt/EBITDA-1.23
Net Debt/FCF—
Balance Sheet
Debt/Equity0.37
Current Ratio4.16
Quick Ratio3.67
Book Value/Sh8.17 USD
Cash/Share5.68 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:33
Split DateMay 4, 2023
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)82.00 USD
Upside (mean)+66.5%
Target Range65.00 USD – 102.00 USD
65.00+66.5% to mean102.00
# Analysts8
Ownership
Shares Out.29.97M
Float20.59M
Insiders7.67%
Institutions114.90%
Short Interest
Short Ratio8.0d
Short % Float41.71%
Short % Out.21.88%
Shares Short6.55M
Short (prev mo.)5.63M
Technical
SMA 5073.13 (-32.7%)
SMA 20069.67 (-29.3%)
Beta1.99
S&P 52W Chg12.08%
Avg Vol (30d)1.04M
Avg Vol (10d)1.27M
Technical Indicators
RSI (14)36.7
MACD-5.4915
MACD Signal-4.5235
MACD Hist.-0.9680
BB Upper74.74 USD
BB Middle59.66 USD
BB Lower44.57 USD
BB Width50.56%
ATR (14)5.994 USD
Vol Ratio (20d)0.75x

About GeneDx Holdings (NASDAQ: WGS)

›

GeneDx Holdings (NASDAQ: WGS) is listed on Nasdaq, where its shares trade in USD. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 1,300 employees.

The shares were at 49.24 USD on 19 November 2026, down 64.0% over 52 weeks. Its 52-week range is 32.21 USD to 170.87 USD: the price is 71.2% below the high and 52.9% above the low.

Its market capitalisation is 1.48B USD.

GeneDx Holdings reports return on equity of -6.8%, an operating margin of -13.7% and revenue up 5.4% year over year.

Its debt exceeds its cash by 45.27M USD, a debt-to-equity ratio of 0.37. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 8 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 82.00 USD is 66.5% above the current price. The next earnings report is expected on 22 February 2027.